Ebolavirus in West Africa, and the use of experimental therapies or vaccines

Response to the current ebolavirus outbreak based on traditional control measures has so far been insufficient to prevent the virus from spreading rapidly. This has led to urgent discussions on the use of experimental therapies and vaccines untested in humans and existing in limited quantities, rais...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoenen, Thomas, Feldmann, Heinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177057/
https://www.ncbi.nlm.nih.gov/pubmed/25286348
http://dx.doi.org/10.1186/s12915-014-0080-6
_version_ 1782336710197116928
author Hoenen, Thomas
Feldmann, Heinz
author_facet Hoenen, Thomas
Feldmann, Heinz
author_sort Hoenen, Thomas
collection PubMed
description Response to the current ebolavirus outbreak based on traditional control measures has so far been insufficient to prevent the virus from spreading rapidly. This has led to urgent discussions on the use of experimental therapies and vaccines untested in humans and existing in limited quantities, raising political, strategic, technical and ethical questions.
format Online
Article
Text
id pubmed-4177057
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41770572014-09-28 Ebolavirus in West Africa, and the use of experimental therapies or vaccines Hoenen, Thomas Feldmann, Heinz BMC Biol Opinion Response to the current ebolavirus outbreak based on traditional control measures has so far been insufficient to prevent the virus from spreading rapidly. This has led to urgent discussions on the use of experimental therapies and vaccines untested in humans and existing in limited quantities, raising political, strategic, technical and ethical questions. BioMed Central 2014-09-26 /pmc/articles/PMC4177057/ /pubmed/25286348 http://dx.doi.org/10.1186/s12915-014-0080-6 Text en © Hoenen and Feldmann; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Opinion
Hoenen, Thomas
Feldmann, Heinz
Ebolavirus in West Africa, and the use of experimental therapies or vaccines
title Ebolavirus in West Africa, and the use of experimental therapies or vaccines
title_full Ebolavirus in West Africa, and the use of experimental therapies or vaccines
title_fullStr Ebolavirus in West Africa, and the use of experimental therapies or vaccines
title_full_unstemmed Ebolavirus in West Africa, and the use of experimental therapies or vaccines
title_short Ebolavirus in West Africa, and the use of experimental therapies or vaccines
title_sort ebolavirus in west africa, and the use of experimental therapies or vaccines
topic Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177057/
https://www.ncbi.nlm.nih.gov/pubmed/25286348
http://dx.doi.org/10.1186/s12915-014-0080-6
work_keys_str_mv AT hoenenthomas ebolavirusinwestafricaandtheuseofexperimentaltherapiesorvaccines
AT feldmannheinz ebolavirusinwestafricaandtheuseofexperimentaltherapiesorvaccines

Ejemplares similares